The City of Denver issued its first license specifically for medical marijuana research and development. Med Pharm received the license to begin examining the effects of marijuana on Alzheimer’s disease.

“We are excited for the possibilities for this type of medical research to find effective research for a whole host of illnesses,” said Ashley Kilroy, the City of Denver’s Executive Director of Excise and Licenses. “Also we really see this license-type in particular, a license that could attract some of the best and brightest to Denver to attract this type of work.”

Med Pharm, a phytopharmaceutical and intellectual property holding company, was created to develop innovative cannabis products, using accepted pharmaceutical formulation techniques, to reliably produce identifiable and replicable dosage forms for human use.  And Colorado Leads member, Andy Williams, is on its board.